A Study of IMC-1 In Patients With Fibromyalgia

Summary

This is a randomized, double-blind, placebo-controlled, 16-week study designed to evaluate the hypothesis that tissue-resident herpes virus may be causally related to fibromyalgia symptoms or recurrence. IMC-1 is a combination treatment that is designed to suppress this suspected virus and thus alleviate fibromyalgia symptoms.

Timeline

Start

2013-05

Primary completion

2014-01

Completion

2014-03

Drugs

Indications